Magdalen College, Oxford

HealthTech Leader Cera Strengthens Advisory Board With Addition of New Members

Retrieved on: 
Wednesday, April 17, 2024
Mental Health, Technology, Managed Care, Medical Devices, General Health, Public Policy, Government, Healthcare Reform, Hospitals, Neurology, Health, Health Technology, Telecommunications, Telemedicine, Virtual Medicine, Software, Other Health, Practice Management, Artificial Intelligence, Ed Miliband, NHS, Guardian, COVID, Tech, Peter Mandelson, Policy, House, Magdalen College, Oxford, Advisory board, Innovation, Research, Dementia, Social work, Entrepreneurship, The, A&E, Nursing, Communes of Burundi, Patient, Politics, Pressure, Cabinet, Multimedia, Wood, Urinary tract infection, Cabinet Office, Senior advisor, The Guardian

Cera, the award-winning digital home healthcare provider, today announces the appointment to its Advisory Board of four new members: Lord Wood of Anfield, Hilary Evans, Benjamin Wegg-Prosser and Samantha Jones.

Key Points: 
  • Cera, the award-winning digital home healthcare provider, today announces the appointment to its Advisory Board of four new members: Lord Wood of Anfield, Hilary Evans, Benjamin Wegg-Prosser and Samantha Jones.
  • He was appointed to the House of Lords in 2011 and is a Fellow of Magdalen College, Oxford, and Oxford’s Blavatnik School of Government.
  • Lord Wood will advise Cera as it continues to work collaboratively with government and the NHS to build a healthcare system fit for the future.
  • Since leaving public office full-time, Ms Jones has been appointed as the lead NED at the Department of Health & Social Care.

Grain Management Welcomes Franklin Raines as Senior Advisor

Retrieved on: 
Thursday, September 28, 2023
University of Oxford, AOL, Fannie Mae, Senior advisor, Intelligence, General partnership, Rhodes, Harvard College, Harvard Law School, PepsiCo, TIAA, WarnerMedia, Magdalen College, Oxford, JD, Bangladesh Technical Education Board, Management, Growth, Grain de Sel Togo, Inc., Ecosystem, BA, Boeing, Pfizer

WASHINGTON, Sept. 28, 2023 /PRNewswire/ -- Grain Management, LLC ("Grain"), investment firm and solutions provider to the global broadband industry, announced today that Franklin Raines has joined its board as a Senior Advisor.

Key Points: 
  • WASHINGTON, Sept. 28, 2023 /PRNewswire/ -- Grain Management, LLC ("Grain"), investment firm and solutions provider to the global broadband industry, announced today that Franklin Raines has joined its board as a Senior Advisor.
  • For the past fifteen years Raines has been a private investor in technology companies across various sectors including cyber security and artificial intelligence.
  • Grain's Senior Advisors collaborate with the Firm's leadership team and portfolio companies, providing perspectives gained from extensive experience in their fields.
  • Raines said, "Grain is a leading investor in the broadband ecosystem, and I look forward to working with David and the rest of the team as they create value across the Grain portfolio."

Fountain Life Appoints Rakesh M. Suri, M.D., D.Phil., as President and Chief Medical Officer

Retrieved on: 
Thursday, October 13, 2022
Physician, Health, Editorial board, LinkedIn, Magdalen College, Oxford, Disease, Mayo Clinic, Queen's University, Life, Holm–Bonferroni method, American Board of Commissioners for Foreign Missions, The Journal of Thoracic and Cardiovascular Surgery, General surgery, Family, Longevity, Research, Instagram, American Board of Thoracic Surgery, Division, Queen, Facebook, Technology, Cancer, University, Cleveland, CEO, Cleveland Clinic, Journal, Artificial intelligence, Mayo College, Tesco international operations, FDA, Cardiothoracic surgery, Harvard Business School, Pharmaceutical industry

NAPLES, Fla., Oct. 13, 2022 /PRNewswire/ -- Fountain Life, a preventative health and longevity company committed to transforming global healthcare from reactive to proactive, today announced the appointment of Rakesh M. Suri, M.D., D.Phil., as the company's first President and Chief Medical Officer. Dr. Suri is an accomplished cardiac surgeon and prior executive leader at the Cleveland Clinic. In this new role, he will focus on the domestic and global expansion of Fountain Life's operations, including the establishment of partnerships with payers, community developers, corporate entities and wellness-oriented businesses. The mission of Fountain Life is to bring state-of-the-art diagnostics to detect disease early and to optimize and track the health of members in an experience-focused, technology-enabled and provider-led medical setting.

Key Points: 
  • The mission of Fountain Life is to bring state-of-the-art diagnostics to detect disease early and to optimize and track the health of members in an experience-focused, technology-enabled and provider-led medical setting.
  • "Fountain Life is a growing company that aims to transform healthcare through innovative data-driven technologies that help diagnose illnesses at their earliest stages," said William Kapp, M.D., Fountain Life's CEO and co-founder.
  • Before joining Fountain Life, Dr. Suri was President of International Operations and a practicing cardiothoracic surgeon at Cleveland Clinic in Ohio.
  • Fountain Life brings together the world's most renowned scientists and physicians to boost longevity and performance putting health back in healthcare.

Ellison Institute Expands Planned Oxford Campus

Retrieved on: 
Monday, July 18, 2022
Research, University, Acquisition, CEO, Entrepreneurship, Cancer, Tony Blair Institute for Global Change, Oxford Science Park, Park, Lawrence, Engineering, Southwest Border Security Consortium, Magdalen College, Oxford, Technology, Heart, Ellison, GIC, Multimedia, Infection, University of Oxford, Health policy, Laboratory, OXFORD, Health, Oxford Nanopore Technologies, Global Health, Partnership, COVID-19, Institute, Biomedical Research, Management, Pharmaceutical industry

OXFORD, United Kingdom, July 18, 2022 /PRNewswire/ -- The Lawrence J. Ellison Institute for Transformative Medicine is adding to its planned Oxford scientific campus, which will be a permanent home to research laboratories, a patient clinic, educational facilities, and collaborative spaces in support of the Ellison Institute's research and healthcare strategy.

Key Points: 
  • "We look forward to continuing the development of our Oxford presence and partnerships," said Dr. David Agus, founding director and CEO of the Ellison Institute.
  • Rory Maw, CEO of The Oxford Science Park, said, "We're delighted to welcome the Ellison Institute to the Park and look forward to working with the team to help deliver their vision for the new Oxford campus.
  • The Global Health Security Consortium (GHSC), a joint initiative of the Tony Blair Institute for Global Change, the Ellison Institute, and the University of Oxford, will be one of the many Ellison Institute projects based out of the new campus.
  • The new campus will also enable the Ellison Institute to build collaborations with local companies such as Oxford Nanopore , also located within The Oxford Science Park.